Donor choice according to age for allo-SCT for AML in complete remissionAYUK, F; ZABELINA, T; WORTMANN, F et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 8, pp 1028-1032, issn 0268-3369, 5 p.Article

Interactive diagnostics in the indication to allogeneic SCT in AMLBACHER, U; HAFERLACH, C; SCHNITTGER, S et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 10, pp 745-756, issn 0268-3369, 12 p.Article

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemiaSCHNITTGER, S; BACHER, U; KERN, W et al.Leukemia. 2011, Vol 25, Num 8, pp 1297-1304, issn 0887-6924, 8 p.Article

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44⁺) and T (HLA-DR⁺) cellsLIOZNOV, M; EL-CHEIKH, J; FEHSE, B et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 349-353, issn 0268-3369, 5 p.Article

Three-dimensional computer morphometry of the maxilla and face in Infants with Pierre Robin sequence : A comparative studyBACHER, M; BACHER, U; BACHER, A et al.The Cleft palate-craniofacial journal. 2000, Vol 37, Num 3, pp 292-302, issn 1055-6656Article

Three-dimensional analysis of cleft palate topology in newborn infants with reference to the cranial skeletonBACHER, M; GÖZ, G; THINH PHAM et al.The Cleft palate-craniofacial journal. 1998, Vol 35, Num 5, pp 379-395, issn 1055-6656Article

Evaluation of BM cytomorphology after allo-SCT in patients with MDSCHRISTOPEIT, M; OCHENI, S; BOKEMEYER, C et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 3, pp 465-466, issn 0268-3369, 2 p.Article

Evaluation of BM cytomorphology after allo-SCT in patients with AMLCHRISTOPEIT, M; MIERSCH, K; KRÖGER, N et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 12, pp 1538-1544, issn 0268-3369, 7 p.Article

Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donorsNETH, O. W; BACHER, U; THIEBAUT, R et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 13-19, issn 0268-3369, 7 p.Article

AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic featuresHAFERLACH, T; KOHLMANN, A; HAFERLACH, C et al.Leukemia. 2009, Vol 23, Num 5, pp 934-943, issn 0887-6924, 10 p.Article

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patientsKRÖGER, N; ZABELINA, T; BACHER, U et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 3, pp 403-407, issn 0268-3369, 5 p.Article

Circulating CD34⁺ cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCTALCHALBY, H; LIOZNOV, M; FRITZSCHE-FRIEDLAND, U et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 1, pp 143-145, issn 0268-3369, 3 p.Article

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceLE GOUILL, S; KRÖGER, N; RIO, B et al.Annals of oncology. 2012, Vol 23, Num 10, pp 2695-2703, issn 0923-7534, 9 p.Article

Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatmentHAFERLACH, C; BACHER, U; SCHNITTGER, S et al.Leukemia. 2010, Vol 24, Num 3, pp 638-640, issn 0887-6924, 3 p.Article

Minimal residual disease diagnostics in myeloid malignancies in the post transplant periodBACHER, U; ZANDER, A. R; HAFERLACH, T et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 145-157, issn 0268-3369, 13 p.Article

Impact of physiological BM CD10 + CD19 + B-cell precursors (haematogones) in the post-transplant period in patients with AMLCHRISTOPEIT, M; HEILAND, A; BINDER, M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 9, pp 1257-1259, issn 0268-3369, 3 p.Article

Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaKRÖGER, N; ZABELINA, T; AYUK, F et al.Leukemia. 2011, Vol 25, Num 10, pp 1657-1661, issn 0887-6924, 5 p.Article

The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AMLHAFERLACH, C; BACHER, U; HAFERLACH, T et al.Leukemia. 2011, Vol 25, Num 5, pp 874-877, issn 0887-6924, 4 p.Article

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCTALCHALBY, H; BADBARAN, A; BOCK, O et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 9, pp 1404-1407, issn 0268-3369, 4 p.Article

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count : a study on 162 patientsSCHNITTGER, S; BACHER, U; HAFERLACH, C et al.Leukemia. 2007, Vol 21, Num 4, pp 725-731, issn 0887-6924, 7 p.Article

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?KLYUCHNIKOV, E; BACHER, U; KROLL, T et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 1, pp 1-7, issn 0268-3369, 7 p.Article

Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristicsBACHER, U; KERN, W; ALPERMANN, T et al.Leukemia. 2011, Vol 25, Num 8, pp 1361-1364, issn 0887-6924, 4 p.Article

Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasmsSCHNITTGER, S; BACHER, U; HAFERLACH, C et al.Leukemia. 2011, Vol 25, Num 4, pp 615-621, issn 0887-6924, 7 p.Article

MUTYH-associated polyposis ― variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutationsMORAK, M; LANER, A; BACHER, U et al.Clinical genetics. 2010, Vol 78, Num 4, pp 353-363, issn 0009-9163, 11 p.Article

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCTOCHENI, S; KROEGER, N; KABISCH, H et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 181-186, issn 0268-3369, 6 p.Article